SEC Form 4/A · accession 0001424422-16-000036
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Stephen Morlock
Director
Period of report
Nov 28, 2016
Accepted (ET)
Nov 29, 2016 · 7:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Nov 28, 2016 | P | 428,571 | $0.35 | A | 543,956 | D | |
| Common stockF1 | holding | — | — | — | 251,071 | I | By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants to purchase common stockF2,F3,F4 | $0.35 | Nov 28, 2016 | P | 321,428 | A | — | — | Common stock | 321,428 | 321,428 | D |
Explanation of responses
- F1Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03
- F2Securities are purchased as a unit, priced at $0.35 per unit, which consists of one share of common stock and one warrant to purchase 0.75 of a share of common stock.
- F3Warrants become exercisable upon the later of the one year anniversary from issuance and receiving stockholder approval to increase the number of authorized shares of common stock.
- F4Warrants expire 7 years from the exercisability date.